The DOI matches its Crossref record; 136 of the 140 references it cites were found in a registry or an index.
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Open accessAbstract
Epidemiological data on a wide range of mental disorders from community studies conducted in European countries are presented to determine the availability and consistency of prevalence, disability and treatment findings for the EU. Using a stepwise multimethod approach, 27 eligible studies with quite variable designs and methods including over 150,000 subjects from 16 European countries were identified. Prevalence: On the basis of meta-analytic techniques as well as on reanalyses of selected data sets, it is estimated that about 27% (equals 82.7 million; 95% CI: 78.5-87.1) of the adult EU population, 18-65 of age, is or has been affected by at least one mental disorder in the past 12 months. Taking into account the considerable degree of comorbidity (about one third had more than one disorder), the most frequent disorders are anxiety disorders, depressive, somatoform and substance dependence disorders. When taking into account design, sampling and other methodological differences between studies, little evidence seems to exist for considerable cultural or country variation. Disability and treatment: despite very divergent and fairly crude assessment strategies, the available data consistently demonstrate (a) an association of all mental disorders with a considerable disability burden in terms of number of work days lost (WLD) and (b) generally low utilization and treatment rates. Only 26% of all cases had any consultation with professional health care services, a finding suggesting a considerable degree of unmet need. The paper highlights considerable future research needs for coordinated EU studies across all disorders and age groups. As prevalence estimates could not simply be equated with defined treatment needs, such studies should determine the degree of met and unmet needs for services by taking into account severity, disability and comorbidity. These needs are most pronounced for the new EU member states as well as more generally for adolescent and older populations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in line with the higher prevalence of women who make use of mental healthcare services”
From Patients requesting and receiving euthanasia for psychiatric disorders in the Netherlands (2023) · cites this paper as [12]
In the citing paper
“In Europe, only about 25% of people with mental disorders receive professional treatment (Wittchen and Jacobi, 2005).”
From Feasibility of a Software agent providing a brief Intervention for Self-help to Uplift psychological wellbeing (“SISU”). A single-group pretest-posttest trial investigating the potential of SISU to act as therapeutic agent (2021) · cites this paper as Wittchen and Jacobi, 2005
In the citing paper
“It is the case that many with anxiety disorders have no diagnosis nor seek treatment [29,30].”
From Low-intensity internet-delivered treatment for generalized anxiety symptoms in routine care: protocol for a randomized controlled trial (2014) · cites this paper as [30]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392 · cited 1×
“The only available cross-national and directly comparative data in this respect come from the ESEMeD study revealing that health-related quality of life (mental health score of the SF12, Ware et al., 1996) was reduced by approximately 1.0 standard deviation units in most mental disorders.”
ResultInfluentialDiagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,603
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370 · cited 3×
“Consistent with the international situation and other inquiries (e.g. Kessler et al., 1994; Fryers et al., 2004), almost no community studies with established explicit diagnostic criteria were identified with regard to other mental disorders such as sleep disorders, impulse control disorders,…”
BackgroundResultDiagnostic and Statistical Manual of Mental Disorders, 3rd ed
Cooper, A. M., & Michels, R. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.128 · Cited by 7,419
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,899
A scaled version of the General Health Questionnaire
Goldberg, D. P., & Hillier, V. F. (1979) · Psychological Medicine · doi:10.1017/s0033291700021644 · Cited by 5,639 · cited 1×
“We did not include studies assessing psychopathology and mental health exclusively by means of questionnaires or screening instruments (e.g. GHQ, Goldberg and Hillier, 1979; CIDI-SF, Kessler et al., 1998; MHI-5, Berwick et al., 1991).”
Method
Research works printed but not linked: 6
- Andrade, 2000, Cross-national comparisons of the prevalences and correlates of mental disorders, B. World Health Organ., 78, 413
- Jacobi, 2004, Psychische Störungen in der Allgemeinbevölkerung: Inanspruchnahme von Gesundheitsleistungen und Ausfalltage, Bundesgesundheitsblatt Gesundh. Forsch. Gesundh.Schutz, 47, 736
- Meyer, 2001, Prevalence of DSM-IV psychiatric disorders including nicotine dependence in the general population: results from the northern german TACOS study, Neurol. Psychiatr. Br., 9, 75
- Szadoczky, 2000, A hangulat- es szorongasos zavarok elöfordulasa a felnott magyar lakossag köreben, Orv. Hetil., 141, 17
- The WHO World Mental Health Survey Consortium, 2004, Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys, J. Am. Med. Assoc., 291, 2581, 10.1001/jama.291.21.2581 · DOI · Paper page
- Wittchen, 2003, Depression—an underdiagnosed disease, Medicographia, 25, 9
Cited by
Sorted by citations
Items 601–700 of 1,000
Harrison, H., Burns, M., Darko, N., & Jones, C. R. (2023) · Perspectives in Public Health · doi:10.1177/17579139231170768 · Cited by 20
“Health Technol Assess 2010;14(8):1–93.”
Economic evaluation of audio based resilience training for depression in primary care
Koeser, L., Dobbin, A., Ross, S., & McCrone, P. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.044 · Cited by 19
Stjernswärd, S., & Hansson, L. I. (2016) · Informatics for Health and Social Care · doi:10.1080/17538157.2016.1177533 · Cited by 20
“2%, which is an increasing source of burden as measured by disability adjusted life years (1,2).”
BackgroundBasic features of generalized anxiety disorder
Zuardi, A. W. (2017) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v50isupl1.p51-55 · Cited by 20
Görges, F., Oehler, C., von Hirschhausen, E., Hegerl, U., & Rummel‐Kluge, C. (2018) · Internet Interventions · doi:10.1016/j.invent.2018.03.001 · Cited by 19
Blay, S. L., Fillenbaum, G. G., Mello, M. F., Quintana, M. I., Mari, J. D. J., Bressan, R. A., & Andreoli, S. B. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.023 · Cited by 22
Panic disorders: The role of genetics and epigenetics
Kim, E. J., & Kim, Y. (2018) · Global Medical Genetics · doi:10.3934/genet.2018.3.177 · Cited by 19
“In study done at 2005 showed DALY for panic disorder was 383,783, which was smaller than that of depression, dementia but greater than that of Parkinson’s disease, epilepsy, which are known to have still big social cost or burden [6].”
BackgroundKählke, F., Berger, T., Schulz, A., Baumeister, H., Berking, M., Cuijpers, P. J., Bruffaerts, R., Auerbach, R. P., Kessler, R. C., & Ebert, D. D. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2125-4 · Cited by 20
“Thus, treatment of SAD is of particular interest to the public healthcare system and health services in and outside of university [11, 12], especially as SAD may become a chronic condition when left untreated [13].”
BackgroundDisease Burden and Disability-Adjusted Life Years Due to Schizophrenia and Psychotic Disorders
Theodoridou, A., & Wulf Rössler, A. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_87 · Cited by 19
Interactive Effects of Anxiety Sensitivity and Emotion Regulation on Anxiety Symptoms
Allan, N. P., Norr, A. M., Macatee, R. J., Gajewska, A., & Schmidt, N. B. (2015) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-015-9484-z · Cited by 19
Saariaho, T., Saariaho, A., Karila, I., & Joukamaa, M. I. (2011) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.737 · Cited by 21
Contribution of attachment insecurity to health-related quality of life in depressed patients
Ponizovsky, A. M. (2013) · World Journal of Psychiatry · doi:10.5498/wjp.v3.i2.41 · Cited by 19
Antidepressant effect of recombinant NT4-NAP/AAV on social isolated mice through intranasal route
Liu, F., Liu, Y., Lei, G., Liu, P., Chu, Z., Gao, C., & Dang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.14356 · Cited by 20
“The life time prevalence of depressive disorder ranging between 15% and 20%[2], with an onset at different points in life and lasts for a varying amount of time.”
BackgroundPrevalence of mental diseases in Austria
Łaszewska, A., Österle, A., Wancata, J., & Simon, J. (2018) · Wiener klinische Wochenschrift · doi:10.1007/s00508-018-1316-1 · Cited by 20
The full cost and burden of disorders of the brain in Europe exposed for the first time
Nutt, D. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.005 · Cited by 19
Suicides in psychiatric in-patients: what are we doing wrong?
Leo, D. D., & Svetičič, J. (2010) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001536 · Cited by 19
“However, under-provision of resources constitutes the most important barrier to effective mental health care, even in the highest-income countries, with most mentally disordered people receiving no effective care (Wittchen & Jacobi, 2005; Saxena et al., 2007).”
BackgroundForkmann, T., Norra, C., Wirtz, M. A., Gauggel, S., & Boecker, M. (2010) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2010.04.021 · Cited by 18
Psychopathology, Defence Mechanisms, and the Psychosocial Work Environment
Larsen, A., Bøggild, H., Mortensen, J. T., Foldager, L., Hansen, J. C., Christensen, A., Arendt, M. C. B. B., Rosenberg, N., & Munk‐Jørgensen, P. (2009) · International Journal of Social Psychiatry · doi:10.1177/0020764008099555 · Cited by 18
“Psychiatric diseases like depression and anxiety are common (Wittchen & Jacobi, 2005).”
BackgroundMeidl, V., Dallmann, P., Leonhart, R., Bretthauer, B., Busch, A., Kubosch, E. J., Wrobel, N., & Hirschmüller, A. (2023) · PM&R · doi:10.1002/pmrj.13011 · Cited by 20
Fritzsche, K., Scheib, P., Wirsching, M., Schübler, G., Wu, W., Cát, N. H., Vongphrachanh, S., Linh, N. T., & Workgroup, A.-L. (2008) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.38.1.a · Cited by 18
Tebbe, B. B. M., Terluin, B., & Koelewijn, J. M. (2012) · Midwifery · doi:10.1016/j.midw.2012.05.004 · Cited by 18
“The most common mental health issues are anxiety, depression, substance dependency and somatoform disorders (physical complaints that have a psychological origin) (Andersson et al., 2003; Wittchen and Jacobi, 2005; Van Bussel and Spitz, 2006).”
BackgroundBenecke, C., Huber, D., Staats, H., Zimmermann, J., Henkel, M., Deserno, H., Wiegand‐Grefe, S., & Schauenburg, H. (2016) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2016.62.3.252 · Cited by 18
Marincowitz, C., Koen, N., Löchner, C., & Stein, D. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00012-5 · Cited by 19
Epidemiologie des Substanzkonsums und der Suchterkrankungen in Deutschland
Küfner, H. (2010) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-010-1041-z · Cited by 20
Melzer, J., Schrader, E., Brattström, A., Schellenberg, R., & Saller, R. (2009) · Phytotherapy Research · doi:10.1002/ptr.2771 · Cited by 18
“According to a systematic review of epidemiological studies in Europe, the 12-month prevalence of somatoform disorders is 6.3% (median) in the 18–65 age group and the prevalence of the most severe subgroup, the somatization disorders, ranges from 1.1–2.1% (Wittchen and Jacobi, 2005).”
BackgroundInfluentialde Girolamo, G., Alonso, J., & Vilagut, G. (2006) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00004401 · Cited by 18
Cost of disorders of the brain in Denmark
Olesen, J., Sobscki, P., Truelsen, T. C., Sestoft, D., & Jönsson, B. (2008) · Nordic Journal of Psychiatry · doi:10.1080/08039480801979792 · Cited by 18
Carpallo-González, M., Muñoz‐Navarro, R., González‐Blanch, C., & Vindel, A. C. (2023) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2023.100379 · Cited by 20
“Emotional disorders are prevalent in the general population and constitute one of the main causes of morbidity and disability, imposing an enormous socioeconomic burden (Campo-Arias & Cassiani, 2008; Whiteford, 2015; Wittchen & Jacobi, 2005; Wittchen et al., 2011).”
BackgroundNußbaumer-Streit, B., Morgan, L. C., Reichenpfader, U., Greenblatt, A. M., Hansen, R. A., Noord, M. V., Lux, L. J., Gaynes, B. N., & Gartlehner, G. (2014) · CNS Drugs · doi:10.1007/s40263-014-0169-z · Cited by 17
Bachler, E., Fruehmann, A., Bachler, H., Aas, B., Strunk, G., & Nickel, M. K. (2016) · Journal of Family Therapy · doi:10.1111/1467-6427.12063 · Cited by 19
Work and mental disorders in a German national representative sample
Roesler, U., Jacobi, F., & Rau, R. (2006) · Work & Stress · doi:10.1080/02678370601008463 · Cited by 17
Self-citationMeasuring Stress-Reducing Effects of Virtual Training Based on Subjective Response
Bosse, T., Gerritsen, C., Man, J. D., & Jan Treur, A. (2012) · Lecture notes in computer science · doi:10.1007/978-3-642-34475-6_39 · Cited by 17
“Recent evidence indicates that the costs associated with PTSD, both to individuals and to society as a whole, are extremely high [6, 16].”
BackgroundThe psychosocial difficulties in brain disorders that explain short term changes in health outcomes
Cieza, A., Bostan, C. M., Ayuso‐Mateos, J. L., Oberhauser, C., Bickenbach, J., Raggi, A., Leonardi, M., Vieta, E., & Chatterji, S. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-78 · Cited by 17
“Olesen J, Leonardi M: The burden of brain diseases in Europe.”
BackgroundInfluentialCognitive Education: Constructivist Perspectives on Schooling, Assessment, and Clinical Applications
Carlson, J. S., & Wiedl, K. H. (2013) · Journal of Cognitive Education and Psychology · doi:10.1891/1945-8959.12.1.6 · Cited by 21
Brain structural correlates of alexithymia in patients with major depressive disorder
Förster, K., Enneking, V., Dohm, K., Redlich, R., Meinert, S., Geisler, A. I., Leehr, E. J., Kugel, H., Baune, B. T., Arolt, V., et al. (2020) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.190044 · Cited by 18
“Two questions following from our interpretation should be further investigated in well-powered longitudinal studies using healthy controls with high alexithymia as a risk population for MDD: (1) Do healthy individuals with high alexithymia scores already show a negative association between alexithymia and FFG volume;…”
BackgroundAgomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
Wang, S., Woo, Y. S., Kim, N.-Y., Na, H.-R., Lim, H. K., & Bahk, W. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.3.423 · Cited by 17
“debilitating psychiatric disorder, with lifetime prevalence of 6% [1,2].”
BackgroundOlivares, J. M., Álvarez, E., Carrasco, J. L., Páramo, M. P., & López-Gómez, V. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000087 · Cited by 17
Inpatient psychosomatic treatment of anxiety disorders: comorbidities, predictors, and outcomes
Beutel, M. E., Bleichner, F., von Heymann, F., Tritt, K., & Hardt, J. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 17
European Brain Policy Forum 2009: Depression and the European Society
Spinney, L. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.04.001 · Cited by 17
“Where should that investment be targeted? The statistics offer some clues: the disease is twice as prevalent in women as in men, and women who marry and have children double their risk of developing it, unless they return to work [12].”
BackgroundInfluentialBrand, S., Annen, H., Holsboer‐Trachsler, E., & Blaser, A. B. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.04.010 · Cited by 21
“European epidemiological studies show twelve-month prevalence rates of 1.3% for agoraphobia, 6.4% for specific phobias, and 2.3% for social phobias (Wittchen and Jacobi, 2005; Goodwin et al., 2005).”
BackgroundInfluentialDelfino, J. P., Barragán, E., Botella, C., Braun, S., Bridler, R., Camussi, E., Chafrat, V., Lott, P., Möhr, C., Moragrega, I., et al. (2015) · Psychopathology · doi:10.1159/000381400 · Cited by 19
Conceptualizing and Describing Social Anxiety and Its Disorders
McNeil, D. W., & Randall, C. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-394427-6.00001-7 · Cited by 30
Thapliyal, P., Mitchison, D., Miller, C. L., Bowden, J. A., González‐Chica, D. A., Stocks, N., Touyz, S. W., & Hay, P. (2017) · Eating Disorders · doi:10.1080/10640266.2017.1383788 · Cited by 17
“…of European surveys of adults aged 18–65 years, only 26% of all ED cases had any consultationwith professional healthcare services (Wittchen& Jacobi, 2005) and it is reported that the vast majority of individuals with bulimic-type ED do not receive mental healthcare (Wittchen & Jacobi, 2005).”
BackgroundAn Economic Theory of Depression and its Impact on Health Behavior and Longevity
Strulik, H. (2018) · Journal of Economic Behavior & Organization · doi:10.1016/j.jebo.2018.11.022 · Cited by 19
Factors that influence access to mental health services in South-Eastern Europe
Tirintica, A. R., Anđelković, I., Sota, O., Pîrlog, M. C., Stoyanova, M. B., Mihai, A., & Wallace, N. (2018) · International Journal of Mental Health Systems · doi:10.1186/s13033-018-0255-6 · Cited by 18
Maniadakis, N., Kourlaba, G., Mougiakos, T., Chatzimanolis, I., & Jönsson, L. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-173 · Cited by 17
Commentary: Socioeconomic position and common mental disorders: what do we need to know?
Skapinakis, P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym141 · Cited by 17
Richards, D., Timulak, L., Doherty, G., Sharry, J., McLoughlin, O., Rashleigh, C., Colla, A., & Joyce, C. (2014) · Trials · doi:10.1186/1745-6215-15-145 · Cited by 16
“It is the case that many with anxiety disorders have no diagnosis nor seek treatment [29,30].”
BackgroundBosmans, J. E., Schreuders, B., van Marwijk, H. W., Smit, J. H., van Oppen, P., & van Tulder, M. W. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-98 · Cited by 16
“Background Mental health problems are prevalent, with depression and anxiety being most common [1-3].”
BackgroundCurth, N. K., Brinck-Claussen, U. Ø., Davidsen, A. S., Lau, M. E., Lundsteen, M., Mikkelsen, J. H., Csillag, C., Hjorthøj, C. R., Nordentoft, M., & Eplov, L. F. (2017) · Trials · doi:10.1186/s13063-017-2120-3 · Cited by 17
CLINICAL FEATURES OF ADJUSTMENT DISORDER IN INTERNALLY DISPLACED WOMEN
Herasymenko, L. O., Isakov, R. І., Halchenko, A. V., & Kydon, P. V. (2020) · Wiadomości Lekarskie · doi:10.36740/wlek202006114 · Cited by 16
Thaller, L., Frühauf, A., Heimbeck, A., Voderholzer, U., & Kopp, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116767 · Cited by 16
Ma, R., Romano, E., Vancampfort, D., Firth, J., Stubbs, B., & Koyanagi, A. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.10.002 · Cited by 16
Talebi, M., Taghipour, A., Raouf-Rahmati, A., Farokhani, E. M., Ghaffariyan-Jam, S., Samarghandi, A., Nemati, M., & Nemati, A. (2024) · BMC Public Health · doi:10.1186/s12889-023-17598-0 · Cited by 16
“Epidemiological data from community studies conducted in European countries in 2005 demonstrated that about 27% of the adult EU population, 18–65 of age, have at least one psychological disorder in a 12-month period [7].”
MethodHusain, W., Ijaz, F., Husain, M. A., Zulfiqar, M., & Khalique, J. (2024) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2401011 · Cited by 17
Depression: a diagnosis aptly used?
Wancata, J., & Friedrich, F. (2011) · PubMed · Cited by 16
Tsai, S.-Y., & Sun, W. (2013) · Women & Health · doi:10.1080/03630242.2013.767302 · Cited by 16
Sander, L., Rausch, L., & Baumeister, H. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0209-5 · Cited by 14
“Compared to 2005 data, these authors note that neither a substantial decrease in the prevalence nor improvements in care or treatment were found, and less than a third of people affected received any treatment [5].”
ResultPatient safety priorities in mental healthcare in Switzerland: a modified Delphi study
Mascherek, A., & Schwappach, D. L. B. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011494 · Cited by 16
Tetratricopeptide repeat domain 9A modulates anxiety-like behavior in female mice
Lim, L. W., Shrestha, S., Or, Y. Z., Tan, S. Z. K., Chung, H. H., Sun, Y., Lim, C. L., Khairuddin, S., Lufkin, T., & Lin, V. C. L. (2016) · Scientific Reports · doi:10.1038/srep37568 · Cited by 16
Psychiatrists' treatment preferences for generalized anxiety disorder
Latas, M., Trajković, G., Bonevski, D., Naumovska, A., Latas, D. V., Bukumirić, Z., & Starčević, V. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2643 · Cited by 18
Mayo‐Wilson, E., & Montgomery, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005330.pub3 · Cited by 16
Beiwinkel, T., Hey, S., Bock, O., & Rössler, W. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00249 · Cited by 15
Multicohort study of change in job strain, poor mental health and incident cardiometabolic disease
Hanson, L. L. M., Rod, N. H., Vahtera, J., Peristera, P., Pentti, J., Rugulies, R., Madsen, I. E. H., LaMontagne, A. D., Milner, A. J., Lange, T., et al. (2019) · Occupational and Environmental Medicine · doi:10.1136/oemed-2018-105595 · Cited by 17
“Intermediate 15 454 (54) 2235 (37) 993 (27) 1630 (47) 2941 (49) 42†”
Reardon, C. L., Gorczynski, P. F., Hainline, B. W., Hitchcock, M., Purcell, R., Rice, S., & Walton, C. C. (2021) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2021.05.010 · Cited by 19
Patient experiences with depression care in general practice: a qualitative questionnaire study
Grung, I., Anderssen, N., Haukenes, I., Ruths, S., Smith‐Sivertsen, T., Hetlevik, Ø., & Hjörleifsson, S. (2022) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2022.2074069 · Cited by 17
“Nevertheless, it is reasonable to assume that a large majority of patients who seek help for depression are still being treated by GPs [4,9].”
BackgroundA paradigm shift in the treatment of emotional memory disorders: Lessons from basic science
Kindt, M., & Elsey, J. W. B. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.11.019 · Cited by 16
“Several epidemiological studies confirm that anxiety and trauma-related disorders – which we argue can be understood at least in part as disorders of emotional memory (Kindt, 2014) – are the most prevalent psychiatric conditions and among the most impairing chronic diseases in Europe (Wittchen and Jacobi, 2005) and th…”
BackgroundLee, B. K., & Loomba, R. S. (2022) · Annals of Pediatric Cardiology · doi:10.4103/apc.apc_27_22 · Cited by 15
“9%.[10,11] Compared with our sample, the rates of scores concerning for depression are lower than the prevalence in the general population, while the findings for scores in the anxiety domain have the opposite finding.”
ResultPharmacist-led screening for mental illness: A systematic review
Ou, K., Gide, D. N., El‐Den, S., O’Donnell, L. K., Malone, D. T., & O’Reilly, C. L. (2024) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2024.06.001 · Cited by 15
Focus on GABAA receptor function
Hautzel, H., Müller, H. W., & Nikolaus, S. (2014) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-0647-14-03 · Cited by 15
Development of mobile psychiatry for bipolar disorder patients
Prociów, P., & Crowe, J. A. (2010) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2010.5626759 · Cited by 15
“IPOLAR disorder (BD) is a condition that affects almost 2% of the European population with a similar prevalence on a global scale [1].”
BackgroundAltamura, A. C., Armadoros, D., Jaeger, M., Kernish, R., Locklear, J. C., & Volz, H. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802250056 · Cited by 15
Interpersonelles Integratives Modellprojekt für Geflüchtete mit psychischen Störungen
Brakemeier, E., Zimmermann, J., Erz, E., Bollmann, S., Rump, S., von Kempski, V., Grossmüller, T., Mitelman, A., Gehrisch, J., Spies, J., et al. (2017) · Psychotherapeut · doi:10.1007/s00278-017-0211-y · Cited by 15
Aguilera‐Martín, Á., Gálvez‐Lara, M., Cuadrado, F., Moreno, E. M., García‐Torres, F., Martínez, J. F. V., Corpas, J., Jurado-González, F. J., Muñoz‐Navarro, R., González‐Blanch, C., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03726-4 · Cited by 20
Schmidt-Weitmann, S., Bösch, S., Weidt, S., & Brockes, C. (2014) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2013.0370 · Cited by 15
The Overlap of Obsessive-Compulsive Disorder and Social Phobia and its Treatment
Baldwin, D. S., Brandish, E. K., & Meron, D. (2008) · CNS Spectrums · doi:10.1017/s1092852900026936 · Cited by 16
Influence of vulnerability factors in panic disorder severity
Osma, J., Barrada, J. R., García‐Palacios, A., & Arbona, C. B. (2016) · Psicothema · doi:10.7334/psicothema2015.223 · Cited by 17
Ehrbar, J., Brand, S., Colledge, F., Donath, L., Egger, S., Hatzinger, M., Holsboer‐Trachsler, E., Imboden, C., Schweinfurth, N., Vetter, S., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00322 · Cited by 15
Hetlevik, Ø., Garre-Fivelsdal, G., Bjorvatn, B., Hjörleifsson, S., & Ruths, S. (2019) · Family Practice · doi:10.1093/fampra/cmz026 · Cited by 15
Integrating mental health into primary care in Sverdlovsk.
Jenkins, R., Zd, B., Goldberg, D. P., Gask, L. L., Zacroeva, A. G., Potasheva, A., Krasnov, V. N., & McDaid, D. (2009) · PubMed Central · Cited by 15
Mental health in workplace settings
McDaid, D. (2008) · Cited by 15
Association of sleep duration with mental health: results from a Spanish general population survey
Braçe, O., Duncan, D. T., Correa-Fernández, J., & Garrido‐Cumbrera, M. (2021) · Sleep And Breathing · doi:10.1007/s11325-021-02332-0 · Cited by 14
“5%, almost double that of the adult population of the EU, for whom 7% is affected by mental health [4].”
BackgroundKhot, S., Tubaki, B. R., & Gonugade, V. B. (2022) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2022.100552 · Cited by 14
“Usually 60% have comorbidities with Major Depressive Disorder and other anxiety disorders [7].”
BackgroundNicoloro‐SantaBarbara, J. M., Carroll, J., Minissian, M., Kilpatrick, S. J., Cole, S. W., Merz, C. N. B., & Accortt, E. E. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13619 · Cited by 15
Moustgaard, H., Joutsenniemi, K., & Martikainen, P. (2013) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-013-0711-1 · Cited by 14
“9 %) [21, 22], and differentials in prevalence according to marital status, employment status, and education are of the same magnitude [5, 21, 23].”
BackgroundA Pill for the Ill? Depression, Medicalization and Public Health.
Vilhelmsson, A. (2014) · Socialmedicinsk tidskrift · doi:10.62607/smt.v91i1.43076 · Cited by 14
“This blunting affect has been described in other research as well, where ‘being-on-SSRIs’ meant an increased distance between takers and their worlds and where previously emotionally close became no more important than ‘anyone else’ [15].”
InfluentialSeitz, T., Stastka, K., Schiffinger, M., Turk, B. R., & Löffler‐Stastka, H. (2019) · Bulletin of the Menninger Clinic · doi:10.1521/bumc_2019_83_01 · Cited by 15
Hanson, L. L. M., Madsen, I. E. H., Westerlund, H., Theorell, T., Burr, H., & Rugulies, R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.023 · Cited by 14
“Depressive disorders affect around 6–7% of the adult population in Western countries yearly (Wittchen and Jacobi, 2005; Kessler et al., 2008), and are associated with considerable morbidity and disability (Ustun et al.”
BackgroundThe Devil in the Details: Public Health and Depression
Vilhelmsson, A. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00192 · Cited by 14
Italian psychiatric reform 1978: milestones for Italy and Europe in 2010?
Pycha, R., Giupponi, G., Schwitzer, J., Duffy, D. M., & Conca, A. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0245-z · Cited by 14
“least twice as high across Europe compared with Italy [11].”
BackgroundWu, D., Peng, Y., Zhou, J., Yang, Y., Rao, C.-L., Bai, S., Zhou, X., Chen, J., Liao, L., Liang, Z., et al. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.018 · Cited by 14
“Major depressive disorder (MDD) is a widespread and debilitating psychiatric mood disorder that is associated with increased morbidity and decrease in the quality of life [1,2].”
de Miguel, B. G., Nutt, D., Hood, S. D., & Davies, S. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110372818 · Cited by 14
“, 1994, 2005b) and in Europe (Lépine, 2002; Wittchen and Jacobi, 2005).”
BackgroundMental Ill Health, Public Health and Medicalization
Vilhelmsson, A., Svensson, T., & Meeuwisse, A. (2011) · Public Health Ethics · doi:10.1093/phe/phr030 · Cited by 14
Laaksonen, M., Blomgren, J., & Tuulio‐Henriksson, A. (2015) · Scandinavian Journal of Public Health · doi:10.1177/1403494815618314 · Cited by 14
Pignon, B., Sescousse, G., Amad, A., Benradia, I., Vaïva, G., Thomas, P., Geoffroy, P. A., Roelandt, J.-L., & Rolland, B. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz077 · Cited by 16
Choate, L. H., & Schwitzer, A. M. “. (2009) · Journal of Mental Health Counseling · doi:10.17744/mehc.31.2.2m03184w12805161 · Cited by 14
Psychiatrische Versorgungsepidemiologie
Jäger, M., & Wulf Rössler, A. (2012) · Der Nervenarzt · doi:10.1007/s00115-011-3454-9 · Cited by 17
Halfon, P., Eggli, Y., Decollogny, A., & Seker, E. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-453 · Cited by 14
Chiorri, C., Melli, G., & Smurra, R. (2011) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465810000913 · Cited by 14
“0% in Europe (Wittchen and Jacobi, 2005).”
Zwanzger, P., & Deckert, J. (2007) · Der Nervenarzt · doi:10.1007/s00115-006-2202-z · Cited by 14
Metadata
- Authors
- Wittchen, H.-U., & Jacobi, F.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- ORCID
- Jacobi, Frank
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 15
- Issue
- 4
- Pages
- 357-376
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2107900025
- Cited by
- 1,503
- References
- 140
- Citations by year
- 2026: 14 · 2025: 31 · 2024: 43 · 2023: 64 · 2022: 48 · 2021: 46 · 2020: 57 · 2019: 58 · 2018: 64 · 2017: 75 · 2016: 83 · 2015: 84 · 2014: 103 · 2013: 110 · 2012: 121
- FWCI
- 96.18
- Type
- journal article
- Language
- en
- Open access
- green
- tud.qucosa.de
- Licence
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health and Medical Studies
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- mental illness, prevalence, disability burden, treatment utilization, unmet needs, comorbidities, anxiety disorders, depression, somatoform disorders, substance dependence, lost workdays, European Union, cross-national comparison, adolescent mental health, older adults
- MeSH terms
- Absenteeism, Adolescent, Adult, Age Factors, Aged, Mental Disorders, Disability Evaluation, Europe, Female, Humans, Male, Mental Health Services, Middle Aged, Quality of Life, Residence Characteristics, Review Literature as Topic, Sex Factors, Comorbidity, Prevalence, Cost of Illness, Diagnosis, Dual (Psychiatry), Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review